Acamprosate Overview, Reducing Alcohol Need
Approved by the US Food and Drug Administration, Acamprosate is used to help people that gave up alcohol not to recidivate.
The studies regarding this medicine have not been finalized by now. But it already proved itself very effective, because it reduces the need for alcohol - by reestablishing the number of neuro-transmitter and it diminishes anxiety, behavioral fluctuations an insomnia. It is also been proved that the risk of relapse is reduced by Acamprosate.
But this medicine also gives secondary effects, which re bearable for most people: abdominal pain, nausea, vomiting, headache, drowsiness, rash, flatulence or dizziness. There were only few cases of suicidal tendencies or affections of the kidney.
In case of kidneys affections, Acamprosate is not recommended or used in small quantities.
The results are even more effective in association to naltrexone. Consulting from specialists and support groups can provide even more help together with these medicines combination.
Alcoholism is a very complex disease, with many aspects so it is normal for the treatments to be so, too. The social perspective suggests one way of treatment, and the medical one - another. But the majority of these solutions follow 2 steps: interrupt drinking and replace it by medication, then to provide an actual, then to provide actual assistance-social familial and medical. The factors that encourage alcohol dependence must also be eliminated for the treatment to be a success.